How to clinically assess and treat muscle overactivity in spastic paresis.

  title={How to clinically assess and treat muscle overactivity in spastic paresis.},
  author={Alain P. Yelnik and Olivier Simon and Bernard M. Parratte and Jean-Michel Gracies},
  journal={Journal of rehabilitation medicine},
  volume={42 9},
OBJECTIVE This educational paper aims to describe, in adult patients, the different aspects of muscle overactivity after a central nervous system lesion, including spasticity, spastic dystonia and spastic co-contraction, the assessment of their symptoms and consequences, and therapeutic options. DISCUSSION AND CONCLUSION Clinical evaluation involves the assessment of passive range of motion, angle of catch or clonus, active range of motion, rapid alternating movements and functional… 

Optimal management for people with severe spasticity.

Spasticity is characterized by velocity-dependent increase in tonic stretch reflexes and tendon jerks. Many people affected by spasticity receive late treatment, or no treatment, which greatly

Degenerative Neurological and Neuromuscular Disease Optimal management for people with severe spasticity

Correspondence: Pennie Seibert 1055 N Curtis Road, Boise, ID 83706, USA Tel +1 208 367 6750 Fax +1 208 367 6836 Email Abstract: Spasticity is characterized by velocity-dependent

Current trends in the rehabilitation of patients with spastic paresis with focal brain damage

The use of botulinum neurotoxin for the treatment of spastic paresis of the upper and lower extremities is the preferred method of complex multidisciplinary rehabilitation of patients with spasticity and has the highest level of evidence.

What is the influence of adjunctive therapy on outcome following botulinum neurotoxin (BoNT­A) injection for focal spasticity in adults with neurological conditions?

This study investigated the influence of commonly prescribed adjunctive therapies on goal attainment following BoNT-A injection for focal spasticity in adults with neurological conditions to determine if adherence to therapy improved rehabilitation outcomes in terms of goal attainment.

Spasticity and hyperselective neurectomy in the upper limb.

Spasticity: pathophysiology, evaluation and management

The current understanding of pathophysiology, clinical features and management of spasticity is reviewed, including identification and elimination of triggers.

Poststroke Spasticity Management

Optimal management of poststroke spasticity involves a combined and coordinated compendium of therapies that encompass cost-effective pharmacological and surgical interventions, along with rehabilitative efforts.

Treatment of spasticity in spinal cord injury with botulinum toxin

BT can be both an effective treatment for focal spasticity in SCI and a good coadjuvant for oral treatments in generalizedSpasticity.

The positive and the negative impacts of spasticity in patients with long-term neurological conditions: an observational study

People with MS may experience a greater impact of spasticity than those with other neurological conditions, particularly in the domains of Social Avoidance/Anxiety and Psychological Agitation, although further validation studies are needed.



Pathophysiology of spastic paresis. II: Emergence of muscle overactivity

Each of the three mechanisms of impairment (paresis, contracture, and spastic overactivity) is symmetrically distributed between agonists and antagonists, which generates torque imbalance around joints and limb deformities; each may be best treated focally on an individual muscle‐by‐muscle basis.

Efficacy of botulinum toxin A in upper limb function of hemiplegic patients

In conclusion, botulinum toxin A is efficient in improving hand use in patients with relatively preserved distal motricity, and in increasing comfort in Patients with severe global disorders.

Long-term functional results of selective peripheral neurotomy for the treatment of spastic upper limb: prospective study in 31 patients.

Selective peripheral neurotomy leads to long-term satisfactory improvement in function and/or comfort with a low morbidity rate in appropriately selected patients suffering from severe harmful spasticity of the upper limb that has been refractory to conservative therapy.

Evaluating the role of botulinum toxin in the management of focal hypertonia in adults

Selective use of botulinum toxin to weaken muscles can lead to a reduction in resistance to passive movement about a distal limb joint, which allows for improvements in passive range of movement and focal disability, particularly in patients presenting with focal spasticity of the lower limb.

[Interest of anesthetic blocks for assessment of the spastic patient. A series of 815 motor blocks].

Anesthetic motor blocks represent a necessary and decisive stage procedure as regards spastic patient assessment and are particularly useful to anticipate a new functional balance and simulate treatment.

Pathophysiology of spastic paresis. I: Paresis and soft tissue changes

The pathophysiology of the first two factors causing motor impairment in spastic paresis are focused on: the vicious cycle of paringis–disuse–paresis and the contracture in soft tissues.

A clinical guide to assess the role of lower limb extensor overactivity in hemiplegic gait disorders.

Extensor muscle overactivity is one of the components of gait disorders in stroke patients and a clinical guide for selecting patients before treatment of a supposed disabling spasticity is proposed.

Botulinum toxin type A in the treatment of upper extremity spasticity

BTXA safely reduced upper extremity muscle tone in patients with chronic spasticity after stroke and reported significant improvement on the physician and patient Global Assessment of Response to Treatment at weeks 4 and 6 postinjection.

A comparison of clinical and laboratory measures of spasticity

It is concluded that the muscle tone score overestimates the amount of spasticity because of changes in the non-reflex properties of the spastic extremity and that a reflex score should be used as a clinical measure ofSpasticity.

A double-blind placebo-controlled study of botulinum toxin in upper limb spasticity after stroke or head injury

Botulinum toxin produced beneficial effects in spasticity and passive range of movement in the hemiplegic upper limb and increased the magnitude of response for impairments in some muscle groups but had little effect on duration of response.